Abstract
The records of 142 patients with generalized autoimmune myasthenia gravis who had been treated with steroids as the single immunosuppressive agent, collected at regular intervals, were employed for a retrospective evaluation. The effectiveness of treatment was assessed after 24 months; the data from the 6th and 12th months were also considered. After 24 months, 63.4% of the whole sample had improved (33.8% were in clinical or pharmacological remission); 13.4% were unchanged or had worsened and 22.3% had moved to a different immunosuppressive treatment. The rate of positive outcome was higher in patients over the age of 40 at disease onset.
| Original language | English |
|---|---|
| Pages (from-to) | 33-39 |
| Number of pages | 7 |
| Journal | Acta Neurologica Scandinavica |
| Volume | 84 |
| Issue number | 1 |
| Publication status | Published - 1991 |
Fingerprint
Keywords
- Myasthenia gravis
- Retrospective study
- Steroid treatment
ASJC Scopus subject areas
- Clinical Neurology
- Neuroscience(all)
Cite this
Effectiveness of steroid treatment in myasthenia gravis : A retrospective study. / Cosi, V.; Citterio, A.; Lombardi, M.; Piccolo, G.; Romani, A.; Erbetta, A.
In: Acta Neurologica Scandinavica, Vol. 84, No. 1, 1991, p. 33-39.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Effectiveness of steroid treatment in myasthenia gravis
T2 - A retrospective study
AU - Cosi, V.
AU - Citterio, A.
AU - Lombardi, M.
AU - Piccolo, G.
AU - Romani, A.
AU - Erbetta, A.
PY - 1991
Y1 - 1991
N2 - The records of 142 patients with generalized autoimmune myasthenia gravis who had been treated with steroids as the single immunosuppressive agent, collected at regular intervals, were employed for a retrospective evaluation. The effectiveness of treatment was assessed after 24 months; the data from the 6th and 12th months were also considered. After 24 months, 63.4% of the whole sample had improved (33.8% were in clinical or pharmacological remission); 13.4% were unchanged or had worsened and 22.3% had moved to a different immunosuppressive treatment. The rate of positive outcome was higher in patients over the age of 40 at disease onset.
AB - The records of 142 patients with generalized autoimmune myasthenia gravis who had been treated with steroids as the single immunosuppressive agent, collected at regular intervals, were employed for a retrospective evaluation. The effectiveness of treatment was assessed after 24 months; the data from the 6th and 12th months were also considered. After 24 months, 63.4% of the whole sample had improved (33.8% were in clinical or pharmacological remission); 13.4% were unchanged or had worsened and 22.3% had moved to a different immunosuppressive treatment. The rate of positive outcome was higher in patients over the age of 40 at disease onset.
KW - Myasthenia gravis
KW - Retrospective study
KW - Steroid treatment
UR - http://www.scopus.com/inward/record.url?scp=0025882697&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025882697&partnerID=8YFLogxK
M3 - Article
C2 - 1927259
AN - SCOPUS:0025882697
VL - 84
SP - 33
EP - 39
JO - Acta Neurologica Scandinavica
JF - Acta Neurologica Scandinavica
SN - 0001-6314
IS - 1
ER -